| N° patients | Gender | Median Age |
---|---|---|---|
Training cohort | 140 | 70 M/70 F | 6.2 y (0.1 – 17) |
ALL/MLL- | 90 | 48 M/42 F | 6.51 y (0.88 – 16.5) |
AML/MLL- | 26 | 12 M/14 F | 8.42 y (0.45 – 17) |
ALL/MLL+ | 16 | 8 M/8 F | 2.14 y (0.1 – 14.5) |
AML/MLL+ | 8 | 2 M/6 F | 3.59 y (0.16 – 13.6) |